CALLIDITAS THERAPEUTICS AB (CALT)
Institutional ownership reported to the SEC as of Q3 2024, across 18 quarters.
5
Reporting holders
$95.7K
Reported value
0.0%
Held as options
-15
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Advisors Preferred, LLC | $81.5K | 2,022 | 0.01% | new | NEW |
| RHUMBLINE ADVISERS | $12.2K | 303 | 0.00% | 6q | +50.0%+$4.1K |
| Missouri Trust & Investment Co | $1.4K | 35 | 0.00% | 12q | HELD |
| Crossmark Global Holdings, Inc. | $655 | 16,117 | 0.01% | new | NEW |
| SIMPLEX TRADING, LLC | $15 | options only | 0.00% | 9q | OPTIONS |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 5 | $95.7K | 18,477 | 2 | 1 | 0 | 0.0% |
| Q2 2024 | 20 | $33.6M | 825,321 | 5 | 2 | 7 | 4.1% |
| Q1 2024 | 19 | $19.8M | 882,678 | 2 | 7 | 1 | 3.7% |
| Q4 2023 | 21 | $23.6M | 847,315 | 3 | 3 | 6 | 7.3% |
| Q3 2023 | 18 | $16.8M | 891,415 | 3 | 4 | 4 | 3.3% |
| Q2 2023 | 16 | $14.0M | 880,976 | 2 | 4 | 2 | 1.2% |
| Q1 2023 | 16 | $21.9M | 878,002 | 4 | 5 | 4 | 4.0% |
| Q4 2022 | 15 | $15.9M | 863,260 | 4 | 2 | 2 | 5.1% |
| Q3 2022 | 17 | $14.0M | 882,602 | 5 | 3 | 4 | 4.6% |
| Q2 2022 | 16 | $15.6M | 870,518 | 1 | 4 | 4 | 0.0% |
| Q1 2022 | 19 | $16.9M | 897,872 | 2 | 4 | 6 | 1.2% |
| Q4 2021 | 20 | $31.2M | 1,081,679 | 12 | 4 | 1 | 14.3% |
| Q3 2021 | 13 | $19.7M | 912,924 | 4 | 4 | 2 | 0.0% |
| Q2 2021 | 13 | $32.7M | 1,110,970 | 7 | 3 | 1 | 0.0% |
| Q1 2021 | 14 | $64.5M | 2,334,724 | 8 | 0 | 2 | 0.0% |
| Q4 2020 | 11 | $96.9M | 2,860,742 | 0 | 1 | 7 | 0.0% |
| Q3 2020 | 16 | $68.1M | 2,838,807 | 4 | 2 | 7 | 0.0% |
| Q2 2020 | 23 | $76.2M | 3,278,920 | 23 | 0 | 0 | 0.0% |